BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leijon H, Remes S, Hagström J, Louhimo J, Mäenpää H, Schalin-Jäntti C, Miettinen M, Haglund C, Arola J. Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas. Hum Pathol 2019;86:66-75. [PMID: 30529752 DOI: 10.1016/j.humpath.2018.11.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Maria Lider Burciulescu S, Livia Gheorghiu M. Advances in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas in the Era of Personalized Genetic Diagnostic. Adrenal Glands - The Current Stage and New Perspectives of Diseases and Treatment [Working Title] 2022. [DOI: 10.5772/intechopen.108298] [Reference Citation Analysis]
2 Sakellakis M, Spathas N, Tsaousis KT, Nikitiadis EN, Linardou H, Diakonis VF. Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review. Cureus 2022. [DOI: 10.7759/cureus.27266] [Reference Citation Analysis]
3 Priyadarshini S, Allison DB, Chauhan A. Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic Review. Pharmaceutics 2022;14:1394. [DOI: 10.3390/pharmaceutics14071394] [Reference Citation Analysis]
4 Deng M, Shu Q, Hu M, Chen Y, Cai L. Comparison of 18F-MFBG and 68Ga-DOTATATE PET/CT in the Imaging of Metastatic Paraganglioma and Pheochromocytoma. Clin Nucl Med 2022. [PMID: 35777982 DOI: 10.1097/RLU.0000000000004314] [Reference Citation Analysis]
5 Kuker R, Wang J, Nagornaya N, Bhatia R, Quencer R, Serafini A. Ga-68 DOTATATE PET/CT in the evaluation of paragangliomas and other indeterminate lesions in the head and neck. Indian J Nucl Med 2022;37:350. [DOI: 10.4103/ijnm.ijnm_66_22] [Reference Citation Analysis]
6 Streit L, Moog S, Hugel S, Rame M, Tanguy E, Andry V, Schmid HA, Brunaud L, Bihain F, Nominé-Criqui C, Goumon Y, Lacomme S, Lomazzi S, Vix M, Mutter D, Vitale N, Ory S, Gasman S. Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells. Cancer Lett 2022;524:232-44. [PMID: 34637845 DOI: 10.1016/j.canlet.2021.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Mahajan S, Pandit-taskar N. Imaging in malignant adrenal cancers. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00149-6] [Reference Citation Analysis]
8 Mohr H, Foscarini A, Steiger K, Ballke S, Rischpler C, Schilling F, Pellegata NS. Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment. EJNMMI Res 2021;11:121. [PMID: 34894301 DOI: 10.1186/s13550-021-00855-x] [Reference Citation Analysis]
9 Carrasquillo JA, Chen CC, Jha A, Ling A, Lin FI, Pryma DA, Pacak K. Imaging of Pheochromocytoma and Paraganglioma. J Nucl Med 2021;62:1033-42. [PMID: 34330739 DOI: 10.2967/jnumed.120.259689] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 16.0] [Reference Citation Analysis]
10 Sesti F, Feola T, Puliani G, Centello R, Di Vito V, Bagni O, Lenzi A, Isidori AM, Cantisani V, Faggiano A, Giannetta E. Sunitinib Treatment for Advanced Paraganglioma: Case Report of a Novel SDHD Gene Mutation Variant and Systematic Review of the Literature. Front Oncol 2021;11:677983. [PMID: 34221997 DOI: 10.3389/fonc.2021.677983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Malla SR, Bhalla AS, Manchanda S, Kandasamy D, Kumar R, Agarwal S, Shamim SA, Kakkar A. Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma. Head Neck 2021;43:2611-22. [PMID: 33938085 DOI: 10.1002/hed.26732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Patel M, Tena I, Jha A, Taieb D, Pacak K. Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World. Front Endocrinol (Lausanne) 2021;12:625312. [PMID: 33854479 DOI: 10.3389/fendo.2021.625312] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
13 Ionovici N, Carsote M, Terzea DC, Predescu AM, Rauten AM, Popescu M. Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review. Rom J Morphol Embryol 2020;61:353-9. [PMID: 33544787 DOI: 10.47162/RJME.61.2.05] [Reference Citation Analysis]
14 Ryder SJ, Love AJ, Duncan EL, Pattison DA. PET detectives: Molecular imaging for phaeochromocytomas and paragangliomas in the genomics era. Clin Endocrinol (Oxf) 2021;95:13-28. [PMID: 33296100 DOI: 10.1111/cen.14375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
15 Si Y, Guan J, Xu Y, Chen K, Kim S, Zhou L, Jaskula-Sztul R, Liu XM. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics 2020;12:E1079. [PMID: 33187322 DOI: 10.3390/pharmaceutics12111079] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
16 Yamazaki Y, Gao X, Pecori A, Nakamura Y, Tezuka Y, Omata K, Ono Y, Morimoto R, Satoh F, Sasano H. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients. Front Endocrinol (Lausanne) 2020;11:587769. [PMID: 33193100 DOI: 10.3389/fendo.2020.587769] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
17 Galgano SJ, Sharbidre K, Morgan DE. Multimodality Imaging of Neuroendocrine Tumors. Radiol Clin North Am 2020;58:1147-59. [PMID: 33040854 DOI: 10.1016/j.rcl.2020.07.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Si Y, Kim S, Ou J, Lu Y, Ernst P, Chen K, Whitt J, Carter AM, Markert JM, Bibb JA, Chen H, Zhou L, Jaskula-Sztul R, Liu XM. Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy. Cancer Gene Ther 2021;28:799-812. [PMID: 32684623 DOI: 10.1038/s41417-020-0196-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
19 Ronen N, Ronen S, Cochran E, Giorgadze T. Metastatic atypical meningioma to the parotid gland - A cytopathological correlation. Ann Diagn Pathol 2020;46:151521. [PMID: 32305003 DOI: 10.1016/j.anndiagpath.2020.151521] [Reference Citation Analysis]
20 Jasim S, Jimenez C. Metastatic pheochromocytoma and paraganglioma: Management of endocrine manifestations, surgery and ablative procedures, and systemic therapies. Best Practice & Research Clinical Endocrinology & Metabolism 2020;34:101354. [DOI: 10.1016/j.beem.2019.101354] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
21 Storvall S, Leijon H, Ryhänen E, Louhimo J, Haglund C, Schalin-Jäntti C, Arola J. Somatostatin receptor expression in parathyroid neoplasms. Endocr Connect 2019;8:1213-23. [PMID: 31336364 DOI: 10.1530/EC-19-0260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]